Literature DB >> 6425046

Adverse effects of valproate.

D Schmidt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6425046     DOI： 10.1111/j.1528-1157.1984.tb05636.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN： 0013-9580            Impact factor:   5.864


× No keyword cloud information.
  8 in total

1.  Use of sodium valproate.

Authors:  N Buchanan
Journal:  Indian J Pediatr       Date:  1985 Nov-Dec       Impact factor: 1.967

Review 2.  Antiepileptic drug toxicity: definition and mechanism of action.

Authors:  E Beghi; R Di Mascio
Journal:  Ital J Neurol Sci       Date:  1986-04

Review 3.  Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience.

Authors:  Emilio Perucca
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  [Pharmacotherapy of cancer pain. 3. Adjuvant drugs.].

Authors:  N I Cherny; R K Portenoy; M Raber; M Zenz
Journal:  Schmerz       Date:  1995-03       Impact factor: 1.107

5.  Hyperammonemia and hepatic status during valproate therapy.

Authors:  Rachna Agarwal; Sangeeta Sharma; Neelam Chhillar; Kiran Bala; Neeraj Singh; C B Tripathi
Journal:  Indian J Clin Biochem       Date:  2009-12-30

Review 6.  Concentration-effect relationships of valproic acid.

Authors:  D W Chadwick
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

Review 7.  Effect of antiepileptic drugs on bodyweight: overview and clinical implications for the treatment of epilepsy.

Authors:  Victor Biton
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 8.  Bodyweight gain and anticonvulsants: a comparative review.

Authors:  P Jallon; F Picard
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.